TRxADE HEALTH (MEDS) Insider Trading & Ownership $8.38 +0.32 (+3.97%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TRxADE HEALTH (NASDAQ:MEDS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage48.40%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$129.87 MNumber OfInsiders Selling(Last 3 Years)0 Get MEDS Insider Trade Alerts Want to know when executives and insiders are buying or selling TRxADE HEALTH stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MEDS Insider Buying and Selling by Quarter Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide TRxADE HEALTH Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/25/2022Donald G FellDirectorBuy100$16.20$1,620.00 5/20/2022Surendra K AjjarapuCEOBuy666$195,000.00$129,870,000.00 (Data available from 1/1/2013 forward) MEDS Insider Trading Activity - Frequently Asked Questions Who is on TRxADE HEALTH's Insider Roster? The list of insiders at TRxADE HEALTH includes Donald G Fell, and Surendra K Ajjarapu. Learn more on insiders at MEDS. What percentage of TRxADE HEALTH stock is owned by insiders? 48.40% of TRxADE HEALTH stock is owned by insiders. Learn more on MEDS's insider holdings. TRxADE HEALTH Key ExecutivesMr. Surendra K. Ajjarapu (Age 53)Founder, Chairman, CEO & Secretary Compensation: $354.23kMr. Prashant Patel R.Ph. (Age 50)Founder, President, COO, Interim CFO, Interim Principal Financial & Accounting Officer and Director Compensation: $147.04kDr. Ramesh KenchappaChief Scientific OfficerMr. David M. Saslow Esq.Inhouse CounselDr. Shafaat Pirani Pharm.D.Executive Vice President of Alliance Pharma Solutions, LLC More Insider Trading Tools from MarketBeat Related Companies RAVE Insider Ownership FXLV Insider Ownership HYFM Insider Ownership UGRO Insider Ownership COSM Insider Ownership EDUC Insider Ownership HWH Insider Ownership TAIT Insider Ownership GWAV Insider Ownership GNLN Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:MEDS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRxADE HEALTH, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TRxADE HEALTH With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
